279 related articles for article (PubMed ID: 23200317)
21. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
[TBL] [Abstract][Full Text] [Related]
23. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
24. Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice.
Chi G; Pei JH; Ma QY; Ru YX; Feng ZH
Immunol Lett; 2020 Feb; 218():44-50. PubMed ID: 31794800
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune hepatitis: evolving concepts.
Diamantis I; Boumpas DT
Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
[TBL] [Abstract][Full Text] [Related]
26. Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.
Derkow K; Loddenkemper C; Mintern J; Kruse N; Klugewitz K; Berg T; Wiedenmann B; Ploegh HL; Schott E
Hepatology; 2007 Oct; 46(4):1155-65. PubMed ID: 17657820
[TBL] [Abstract][Full Text] [Related]
27. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
Christen U; Hintermann E
Front Immunol; 2018; 9():163. PubMed ID: 29503645
[TBL] [Abstract][Full Text] [Related]
29. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
[TBL] [Abstract][Full Text] [Related]
30. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis.
Mix H; Weiler-Normann C; Thimme R; Ahlenstiel G; Shin EC; Herkel J; David CS; Lohse AW; Rehermann B
Gastroenterology; 2008 Dec; 135(6):2107-18. PubMed ID: 18773898
[TBL] [Abstract][Full Text] [Related]
31. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
[TBL] [Abstract][Full Text] [Related]
32. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
[TBL] [Abstract][Full Text] [Related]
34. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
Djilali-Saiah I; Fakhfakh A; Louafi H; Caillat-Zucman S; Debray D; Alvarez F
J Hepatol; 2006 Dec; 45(6):844-50. PubMed ID: 17050030
[TBL] [Abstract][Full Text] [Related]
35. Hepatic T Cell Tolerance Induction in An Inflammatory Environment.
Dywicki J; Noyan F; Misslitz AC; Hapke M; Galla M; Schlue J; Liblau RS; Taubert R; Manns MP; Jaeckel E; Hardtke-Wolenski M
Dig Dis; 2018; 36(2):156-166. PubMed ID: 29020680
[TBL] [Abstract][Full Text] [Related]
36. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
37. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
[TBL] [Abstract][Full Text] [Related]
38. Animal models for autoimmune hepatitis.
Christen U; Holdener M; Hintermann E
Autoimmun Rev; 2007 Apr; 6(5):306-11. PubMed ID: 17412303
[TBL] [Abstract][Full Text] [Related]
39. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
40. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
